These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8584935)

  • 1. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development.
    Güler ML; Gorham JD; Hsieh CS; Mackey AJ; Steen RG; Dietrich WF; Murphy KM
    Science; 1996 Feb; 271(5251):984-7. PubMed ID: 8584935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
    Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
    Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the murine model of infection with Leishmania major to reveal the antagonistic effects that IL-4 can exert on T helper cell development and demonstrate that these opposite effects depend upon the nature of the cells targeted for IL-4 signaling.
    Louis JA; Gumy A; Voigt H; Launois P; Rocken M
    Pathol Biol (Paris); 2003 Mar; 51(2):71-3. PubMed ID: 12801805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.
    Himmelrich H; Launois P; Maillard I; Biedermann T; Tacchini-Cottier F; Locksley RM; Röcken M; Louis JA
    J Immunol; 2000 May; 164(9):4819-25. PubMed ID: 10779790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
    Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
    Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling.
    Nishikomori R; Gurunathan S; Nishikomori K; Strober W
    J Immunol; 2001 Jun; 166(11):6776-83. PubMed ID: 11359836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response.
    Muraille E; De Trez C; Brait M; De Baetselier P; Leo O; Carlier Y
    J Immunol; 2003 Apr; 170(8):4237-41. PubMed ID: 12682257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.
    Yamakami K; Akao S; Tadakuma T; Nitta Y; Miyazaki J; Yoshizawa N
    Immunology; 2002 Apr; 105(4):515-23. PubMed ID: 11985672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis.
    Scott P; Hondowicz B; Eaton A; Scharton-Kersten T
    Ann N Y Acad Sci; 1996 Oct; 795():250-6. PubMed ID: 8958936
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-13 is a susceptibility factor for Leishmania major infection.
    Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
    J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major.
    Launois P; Conceiçao-Silva F; Himmerlich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA
    Parasite Immunol; 1998 May; 20(5):223-30. PubMed ID: 9651923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania susceptibility puzzle gets another twist.
    Marx J
    Science; 1996 Feb; 271(5251):912-3. PubMed ID: 8584928
    [No Abstract]   [Full Text] [Related]  

  • 20. Early IL-4 production does not predict susceptibility to Leishmania major.
    Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
    Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.